Prelude Therapeutics Inc
PRLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001678660
No open-market purchases or sales by Prelude Therapeutics Inc insiders were filed in the last 90 days; 75 institutions reported holding it in 13F filings for Q2 2026, worth $264.3M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Prelude Therapeutics Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 62 | 1 | 53 | −8 |
| Shares | 32.7M | 1.70K | 31.8M | −913.7K (−2.8%) |
| Value | $170.9M | $9.00K | $210.3M | +$39.5M (+23.1%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Prelude Therapeutics Inc at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Candriam Luxembourg S.C.A. | 125,619 | $830.0K | 0.01% |
| Dimensional Fund Advisors LP | 14,616 | $97.0K | 0.00% |
| Denali Advisors LLC | 8,200 | $54.0K | 0.03% |
| Simplex Trading, LLC | 470 | $3.00K | 0.00% |
| China Universal Asset Management Co., Ltd. | 448 | $3.00K | 0.00% |
Sold out (13)
Institutions that held Prelude Therapeutics Inc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Rock Springs Capital Management LP | 368,959 | $1.93M |
| Marshall Wace, LLP | 45,716 | $238.0K |
| Ergoteles LLC | 43,500 | $227.0K |
| Cubist Systematic Strategies, LLC | 39,938 | $208.0K |
| Occudo Quantitative Strategies LP | 23,640 | $123.0K |
| Squarepoint Ops LLC | 19,618 | $102.0K |
| Schonfeld Strategic Advisors LLC | 18,000 | $94.0K |
| Delphia (USA) Inc. | 16,940 | $88.0K |
| Corton Capital Inc. | 15,586 | $81.0K |
| Ensign Peak Advisors, Inc | 8,080 | $42.0K |
| New York State Common Retirement Fund | 92 | $0 |
| Credit Suisse AG | 6 | $0 |
| Cutler Group LP | 100 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Prelude Therapeutics Inc at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Brewin Dolphin Wealth Management Ltd | 1,699 | $9.00K |